Analyst Price Targets — PYPD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 17, 2025 3:00 pm | Boobalan Pachaiyappan | Roth Capital | $9.00 | $3.53 | TheFly | PolyPid price target lowered to $9 from $12 at Roth Capital |
| November 4, 2024 12:26 pm | Chase Knickerbocker | Craig-Hallum | $10.00 | $3.33 | StreetInsider | Craig-Hallum Starts PolyPid Ltd. (PYPD) at Buy |
Latest News for PYPD
If approved, D-PLEX100 would address a critical unmet medical need in the prevention of surgical site infections
PETACH TIKVA, Israel, May 20, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today announced that the Company's management will participate in investor meetings at the Craig-Hallum 23rd Annual Institutional Investor Conference on Thursday,…
PolyPid NASDAQ: PYPD said its first quarter marked a transition from late-stage clinical development toward regulatory submission and commercial preparation for D-PLEX100, its lead product candidate for preventing surgical site infections in abdominal colorectal surgery.
PolyPid Ltd. (PYPD) Q1 2026 Earnings Call Transcript
Initiated NDA Submission to the FDA for D-PLEX₁₀₀ ; Completion Expected Imminently U.S. Commercial Partnership Discussions in Late Stages Conference Call Scheduled for Today at 8:30 AM ET PETACH TIKVA, Israel, May 13, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness,…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PYPD.
U.S. House Trading
No House trades found for PYPD.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.